» Articles » PMID: 7712655

Muir-Torre Syndrome

Overview
Journal Dermatol Clin
Specialty Dermatology
Date 1995 Jan 1
PMID 7712655
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The Muir-Torre syndrome is an autosomal dominantly inherited genodermatosis with malignant potential that is characterized by the presence of at least one sebaceous gland tumor (adenoma, epithelioma, or carcinoma) and a minimum of one internal malignancy. The syndrome has been documented in 147 individuals. Associated features in some of the Muir-Torre syndrome patients are colorectal carcinomas and genitourinary neoplasms. More than half of the 292 visceral cancers described in Muir-Torre syndrome patients were colorectal carcinomas; nearly 60% of these tumors were located at or proximal to the splenic flexure. The presence of even a single Muir-Torre syndrome-associated sebaceous tumor warrants serious consideration for further evaluation of that individual for the syndrome. Therefore, initial and periodic examination for internal malignancy should be performed in individuals with such tumors and patients with the syndrome. Also, family members of Muir-Torre syndrome patients should be screened for Muir-Torre syndrome-associated cutaneous lesions and visceral cancers.

Citing Articles

Sebaceous Carcinoma in the Right Inguinal Region with Multiple Metastases and a Poor Prognosis: A Case Report.

Gao Q, Lin Y, Du Y, Du C Cancer Manag Res. 2024; 16:1753-1758.

PMID: 39678042 PMC: 11646468. DOI: 10.2147/CMAR.S491295.


An Unusual Presentation of Synchronous Breast Cancer and Skin Malignancy in a Patient with Lynch Syndrome: A Case Report and Review of the Literature.

Elghobashy M, Siafakas M, Elshafie M, Hejmadi R, Basu N, Shaaban A Biomedicines. 2024; 12(6).

PMID: 38927449 PMC: 11201021. DOI: 10.3390/biomedicines12061242.


Efficacy and Safety of Carbon Dioxide Laser System in the Treatment of Scalp Sebaceous Adenoma With the Use of a New Scanner Unit.

Bonan P, Gallo G, Fusco I, Madeddu F, Zingoni T J Med Cases. 2023; 14(7):251-254.

PMID: 37560545 PMC: 10409540. DOI: 10.14740/jmc4132.


Germline Testing of Mismatch Repair Genes Is Needed in the Initial Evaluation of Patients With Muir-Torre Syndrome-Associated Cutaneous Sebaceous Neoplasms: A Case Series.

Cohen P, Kurzrock R Cureus. 2023; 15(1):e33975.

PMID: 36824550 PMC: 9941027. DOI: 10.7759/cureus.33975.


Kidney Transplant Recipient With Multiple Contemporaneous Malignancies Secondary to Muir-Torre Syndrome.

Qudaih A, Al Ashour B, Naim A, Joudeh A Cureus. 2021; 13(7):e16642.

PMID: 34466316 PMC: 8396404. DOI: 10.7759/cureus.16642.